| __timestamp | Amneal Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 1802274 |
| Thursday, January 1, 2015 | 109679000 | 2512761 |
| Friday, January 1, 2016 | 118757000 | 2894488 |
| Sunday, January 1, 2017 | 109046000 | 8096274 |
| Monday, January 1, 2018 | 230435000 | 7985229 |
| Tuesday, January 1, 2019 | 289598000 | 8994597 |
| Wednesday, January 1, 2020 | 326727000 | 29772000 |
| Friday, January 1, 2021 | 365504000 | 33907000 |
| Saturday, January 1, 2022 | 399700000 | 26579000 |
| Sunday, January 1, 2023 | 429675000 | 49868547 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Amneal Pharmaceuticals, Inc. and Verona Pharma plc have taken distinct paths in optimizing these costs. Amneal's SG&A expenses have surged by over 400%, peaking at approximately $430 million in 2023. This reflects their aggressive expansion strategy. In contrast, Verona Pharma has maintained a more conservative approach, with a modest increase of around 2,700% over the same period, reaching nearly $50 million in 2023. This stark difference highlights Verona's focus on lean operations, while Amneal invests heavily in growth. Understanding these strategies offers valuable insights into how pharmaceutical companies balance cost management with market expansion.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
SG&A Efficiency Analysis: Comparing Novartis AG and Verona Pharma plc
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.